The receipt of a CE mark in Europe for Affirm follows the software gaining US market clearance from the FDA in October 2020.

(Nasdaq: HOLX) today announced that its Affirm ® Contrast Biopsy Software, which combines contrast-enhanced diagnostic ...

Hologic Inc. closed 24.50% short of its 52-week high of $84.67, which the company reached on August 9th.

Shares of Hologic Inc. HOLX slipped 1.46% to $63.53 Wednesday, on what proved to be an all-around rough trading session for ...

Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Aptima® SARS-CoV-2 assay, which was first granted ...

New Mexico Educational Retirement Board cut its position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 3.5% in ...

It's been a mediocre week for Hologic, Inc. ( NASDAQ:HOLX ) shareholders, with the stock dropping 10% to US$64.58 ...

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

HOLX reported adjusted earnings per share (EPS) of $1.03 in the first quarter of fiscal 2025, up 5.1% year over year. The metric surpassed the Zacks Consensus Estimate by 0.9%. The adjustments include ...